Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).

aFrom the Department of Radiology, Section of Neuroradiology, University of Miami School of Medicine/Jackson Memorial Medical Center, Miami (M.J.D.P.); the Harvard School of Public Health, Statistical & Data Analysis Center, AIDS Clinical Trials Group, Boston (C.Y.); the Department of Clinical Neurophysiology, Mount Sinai School of Medicine, New York (D.S.); the Department of Neurology and Laboratory Medicine, Yale University School of Medicine and Department of Veterans Affairs Medical Center, New Haven (J.B.); the Department of Neurology, Washington University School of Medicine, St Louis (D.B.C.); the Department of Neurology Northwestern University School of Medicine, Chicago (B.C.); the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore (J.McA.); and the Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (C.D.H.).